SEARCH

SEARCH BY CITATION

References

  • Appelbaum, F.R., Deisseroth, A.B., Graw, Jr, R.G., Herzig, G.P., Levine, A.S., Magrath, I.T., Pizzo, P.A., Poplack, D.G. & Ziegler, J.L. (1978) Prolonged complete remission following high dose chemotherapy of Burkitt’s lymphoma in relapse. Cancer, 41, 10591063.
  • Aukema, S.M., Siebert, R., Schuuring, E., van Imhoff, G.W., Kluin-Nelemans, H.C., Boerma, E.J. & Kluin, P.M. (2011) Double-hit B-cell lymphomas. Blood, 24, 23192331.
  • Barrans, S., Crouch, S., Smith, A., Turner, K., Owen, R., Patmore, R., Roman, E. & Jack, A. (2010) Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. Journal of Clinical Oncology, 28, 33603365.
  • Bernstein, J.I., Coleman, C.N., Strickler, J.G., Dorfman, R.F. & Rosenberg, S.A. (1986) Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt’s and non-Burkitt’s types). Journal of Clinical Oncology, 6, 847858.
  • Biggar, R.J., Chaturvedi, A.K., Goedert, J.J. & Engels, E.A. (2007) AIDS-related cancer and severity of immunosuppression in persons with AIDS. Journal of National Cancer Institute, 99, 962972.
  • Boerma, E.G., van Imhoff, G.W., Appel, I.M., Veeger, N.J., Kluin, P.M. & Kluin-Nelemans, J.C. (2004) *Gender and age-related differences in Burkitt lymphoma--epidemiological and clinical data from The Netherlands. European Journal of Cancer, 40, 27812787.
  • Burkhardt, B., Oschlies, I., Klapper, W., Zimmermann, M., Woessmann, W., Meinhardt, A., Landmann, E., Attarbaschi, A., Niggli, F., Schrappe, M. & Reiter, A. (2011) Non-Hodgkin’s lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols. Leukemia, 25, 153160.
  • Chao, C., Xu, L., Abrams, D., Leyden, W., Horberg, M., Towner, W., Klein, D., Tang, B. & Silverberg, M. (2010) Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy. AIDS, 24, 17651770.
  • Choi, M.K., Jun, H.J., Lee, S.Y., Kim, K.H., Lim do, H., Kim, K., Ko, Y.H., Kim, W.S. & Kim, S.J. (2009) Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea. Annals of Hematology, 88, 10991106.
  • Connors, J.M. & Klimo, P. (1988) MACOP-B chemotherapy for malignant lymphomas and related conditions: 1987 update and additional observations. Seminars in Hematology, 25, 4146.
  • Dave, S.S., Fu, K., Wright, G.W., Lam, L.T., Kluin, P., Boerma, E.J., Greiner, T.C., Weisenburger, D.D., Rosenwald, A., Ott, G., Müller- Hermelink, H.K., Gascoyne, R.D., Delabie, J., Rimsza, L.M., Braziel, R.M., Grogan, T.M., Campo, E., Jaffe, E.S., Dave, B.J., Sanger, W., Bast, M., Vose, J.M., Armitage, J.O., Connors, J.M., Smeland, E.B., Kvaloy, S., Holte, H., Fisher, R.I., Miller, T.P., Montserrat, E., Wilson, W.H., Bahl, M., Zhao, H., Yang, L., Powell, J., Simon, R., Chan, W.C. & Staudt, L.M. (2006) Molecular diagnosis of Burkitt’s lymphoma. New England Journal of Medicine, 354, 24312442.
  • Diebold, J.E., Jaffe, E.S., Raphael, M. & Warrite, R.A. (2001) Burkitt lymphoma. In: WHO Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (eds E.S.Jaffe, N.L.Harris, H.Stein & J.W.Vardiman), pp. 81184. IARC Press, Lyon France.
  • Diviné, M., Casassus, P., Koscielny, S., Bosq, J., Sebban, C., Le Maignan, C., Stamattoulas, A., Dupriez, B., Raphaël, M., Pico, J.L., Ribrag, V.; GELA & GOELAMS (2005) Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol. Annals of Oncology, 12, 19281935.
  • Dunleavy, K., Pittaluga, S., Wayne, A.S., Shovlin, M., Johnson, J.L., Little, R., Steinberg, S., Cheson, B.D., His, E., Jaffe, E.S. & Wilson, W.H. (2011) MYC + aggressive B-cell lymphomas: novel therapy of untreated Burkitt lymphoma and MYC + diffuse Large B-Cell lymphoma (DLBCL) with DA-EPOCH-R. Annals of Oncology, 22(Suppl 4), Abst. 71.
  • Fenaux, P., Lai, J.L., Miaux, O., Zandecki, M., Jouet, J.P. & Bauters, F. (1989) Burkitt cell acute leukaemia (L3 ALL) in adults: a report of 18 cases. British Journal of Haematology, 73, 371376.
  • Galicier, L., Fieschi, C., Borie, R., Meignin, V., Daniel, M.T., Gérard, L. & Oksenhendler, E. (2007) Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study. Blood, 110, 28462854.
  • Gerrard, M., Cairo, M.S., Weston, C., Auperin, A., Pinkerton, R., Lambilliote, A., Sposto, R., McCarthy, K., Lacombe, M.J., Perkins, S.L., Patte, C. & FAB LMB96 International Study Committee (2008) Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin’s lymphoma: results of the FAB/LMB 96 international study. British Journal of Haematology, 141, 840847.
  • Grigg, A.P. & Seymour, J.F. (2002) Graft versus Burkitt’s lymphoma effect after allogeneic marrow transplantation. Leukaemia & Lymphoma, 43, 889892.
  • Guech-Ongey, M., Simard, E.P., Anderson, W.F., Engels, E.A., Bhatia, K., Devesa, S.S. & Mbulaiteye, S.M. (2010) AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology?Blood, 116, 56005604.
  • Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B. & Gatter, K.C. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International lymphoma study group. Blood, 84, 13611392.
  • Hochberg, J., Waxman, I.M., Kelly, K.M., Morris, E. & Cairo, M.S. (2009) Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science. British Journal of Haematology, 144, 2440.
  • Hoelzer, D., Ludwig, W.D., Thiel, E., Gassmann, W., Löffler, H., Fonatsch, C., Rieder, H., Heil, G., Heinze, B., Arnold, R., Hossfeld, D., Büchner, T., Koch, P., Freund, M., Hiddemann, W., Maschmeyer, G., Heyll, A., Aul, C., Faak, T., Kuse, R., Ittel, T.H., Gramatzki, M., Diedrich, H., Kolbe, K., Fuhr, H.G., Fischer, K., Schadeck-Gressel, C., Weiss, A., Strohscheer, I., Metzner, B., Fabry, U., Gökbuget, N., Völkers, B., Messerer, D. & Uberla, K. (1996) Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood, 87, 495508.
  • Hoelzer, D., Hiddemann, W., Baumann, A., Döhner, H., Dührsen, U., Fietkau, R., Hansmann, M., Hüttmann, A., Irmer, S., Kaun, S., Kneba, M., Reichle, A., Schmid, M., Schmidt-Wolf, I., Thiel, E., Walewski, J. & Gökbuget, N. (2007) High survival rate in adult Burkitt’s Lymphoma/leukemia and diffuse large B-cell lymphoma with mediastinal involvement. Blood, 110, 3448. Abstr. 518.
  • Hummel, M., Bentink, S., Berger, H., Klapper, W., Wessendorf, S., Barth, T.F., Bernd, H.W., Cogliatti, S.B., Dierlamm, J., Feller, A.C., Hansmann, M.L., Haralambieva, E., Harder, L., Hasenclever, D., Kühn, M., Lenze, D., Lichter, P., Martin- Subero, J.I., Möller, P., Müller- Hermelink, H.K., Ott, G., Parwaresch, R.M., Pott, C., Rosenwald, A., Rosolowski, M., Schwaenen, C., Stürzenhofecker, B., Szczepanowski, M., Trautmann, H., Wacker, H.H., Spang, R., Loeffler, M., Trümper, L., Stein, H., Siebert, R. & Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe (2006) A biologic definition of Burkitt’s lymphoma from transcriptional and genomic profiling. New England Journal of Medicine, 23, 24192430.
  • van Imhoff, G.W., van der Holt, B., MacKenzie, M.A., Ossenkoppele, G.J., Wijermans, P.W., Kramer, M.H., van ‘t Veer, M.B., Schouten, H.C., van Marwijk Kooy, M., van Oers, M.H., Raemaekers, J.M., Sonneveld, P., Meulendijks, L.A., Kluin, P.M., Kluin-Nelemans, H.C., Verdonck, L.F. & Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) (2005) Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma. Leukemia, 6, 945952.
  • Johnson, N.A., Savage, K.J., Ludkovski, O., Ben-Neriah, S., Woods, R., Steidl, C., Dyer, M.J., Siebert, R., Kuruvilla, J., Klasa, R., Connors, J.M., Gascoyne, R.D. & Horsman, D.E. (2009) Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood, 114, 22732279.
  • Jost, L.M., Jacky, E., Dommann-Scherrer, C., Honegger, H.P., Maurer, R., Sauter, C. & Stahel, R.A. (1995) Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt’s lymphomas in adult patients. Annals of Oncology, 5, 445451.
  • Just, P.A., Fieschi, C., Baillet, G., Galicier, L., Oksenhendler, E. & Moretti, J.L. (2008) 18F-fluorodeoxyglucose positron emission tomography/computed tomography in AIDS-related Burkitt lymphoma. AIDS Patient Care STDS, 229, 695700.
  • Kaplan, L.D., Lee, J.Y., Ambinder, R.F., Sparano, J.A., Cesarman, E., Chadburn, A., Levine, A.M. & Scadden, D.T. (2005) Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma. Blood, 106, 15381543.
  • Karantanis, D., Durski, J.M., Lowe, V.J., Nathan, M.A., Mullan, B.P., Georgiou, E., Johnston, P.B. & Wiseman, G.A. (2010) 18F-FDG PET and PET/CT in Burkitt’s lymphoma. European Journal of Radiology, 1, e68e73.
  • Kelly, J.L., Toothaker, S.R., Ciminello, L., Hoelzer, D., Holte, H., LaCasce, A.S., Mead, G., Thomas, D., Van Imhoff, G.W., Kahl, B.S., Cheson, B.D., Magrath, I.T., Fisher, R.I. & Friedberg, J.W. (2009) Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens. Clinical Lymphoma Myeloma, 4, 307310.
  • Klapper, W., Szczepanowski, M., Burkhardt, B., Berger, H., Rosolowski, M., Bentink, S., Schwaenen, C., Wessendorf, S., Spang, R., Möller, P., Hansmann, M.L., Bernd, H.W., Ott, G., Hummel, M., Stein, H., Loeffler, M., Trümper, L., Zimmermann, M., Reiter, A. & Siebert, R. (2008) Molecular mechanisms in malignant lymphomas network project of the Deutsche Krebshilfe. Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood, 112, 13741381.
  • Kluin, P.M., Harris, N.L., Stein, H., Leoncira, L., Raphael, M., Campo, E., Jaffe Swerdlow, S.H., Jaffe, E.S., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W. (2008) In: B Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, pp. 265266. IARC Press, Lyon, France.
  • Lacasce, A., Howard, O., Lib, S., Fisher, D., Weng, A., Neuberg, D. & Shipp, M. (2004) Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity. Leukaemia & Lymphoma, 4, 761767.
  • Le Gouill, S., Talmant, P., Touzeau, C., Moreau, A., Garand, R., Juge-Morineau, N., Gaillard, F., Gastinne, T., Milpied, N., Moreau, P., Harousseau, J.L. & Avet-Loiseau, H. (2007) The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica, 10, 13351342.
  • Lee, E.J., Petroni, G.R., Schiffer, C.A., Freter, C.E., Johnson, J.L., Barcos, M., Frizzera, G., Bloomfield, C.D. & Peterson, B.A. (2001) Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251. Journal of Clinical Oncology, 19, 40144022.
  • Leucci, E., Cocco, M., Onnis, A., De Falco, G., van Cleef, P., Bellan, C., van Rijk, A., Nyagol, J., Byakika, B., Lazzi, S., Tosi, P., van Krieken, H. & Leoncini, L. (2008) MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. Journal of Pathology, 4, 440450.
  • Lin, P. & Medeiros, J. (2007) High-grade B-cell lymphoma/leukemia associated with t(14;18) and 8q24/MYC rearrangement: a neoplasm of germinal center immunophenotype with poor prognosis. Haematologica, 92, 12971301.
  • Little, R.F., Pittaluga, S. & Grant, N. (2003) Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood, 101, 46534659.
  • Lones, M.A., Auperin, A., Raphael, M., McCarthy, K., Perkins, S.L., MacLennan, K.A., Ramsay, A., Wotherspoon, A., Gerrard, M., Cairo, M.S. & Patte, C. (2000) Mature B-cell lymphoma/leukemia in children and adolescents: intergroup pathologist consensus with the revised European-American lymphoma classification. Annals of Oncology, 1, 4751.
  • Lopez, T.M., Hagemeister, F.B., McLaughlin, P., Velasquez, W.S., Swan, F., Redman, J.R., Rodriguez, M.A., Tucker, S.L., Silvermintz, K., Johnson, J. & Cabanillas, F. (1990) Small noncleaved cell lymphoma in adults: superior results for stages I-III disease. Journal of Clinical Oncology, 4, 615622.
  • Magrath, I., Adde, M., Shad, A., Venzon, D., Seibel, N., Gootenberg, J., Neely, J., Arndt, C., Nieder, M., Jaffe, E., Wittes, R.A. & Horak, I.D. (1996) Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. Journal of Clinical Oncology, 3, 925934.
  • Maruyama, D., Watanabe, T., Maeshima, A.M., Nomoto, J., Taniguchi, H., Azuma, T., Mori, M., Munakata, W., Kim, S.W., Kobayashi, Y., Matsuno, Y. & Tobinai, K. (2010) Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX- M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL. International Journal of Hematology, 5, 732743.
  • Mead, G.M., Sydes, M.R., Walewski, J., Grigg, A., Hatton, C.S., Pescosta, N., Guarnaccia, C., Lewis, M.S., McKendrick, J., Stenning, S.P., Wright, D. & UKLG LY06 collaborators (2002) An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt’s lymphoma: results of United Kingdom lymphoma group LY06 study. Annals of Oncology, 8, 12641274.
  • Mead, G.M., Barrans, S.L., Qian, W., Walewski, J., Radford, J.A., Wolf, M., Clawson, S.M., Stenning, S.P., Yule, C.L., Jack, A.S., UK National Cancer Research Institute Lymphoma Clinical Studies Group & Australasian Leukaemia and Lymphoma Group (2008) A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). Blood, 6, 248260.
  • Mohamedbhai, S.G., Sibson, K., Marafioti, T., Kayani, I., Lowry, L., Goldstone, A.H., Linch, D.C. & Ardeshna, K.M. (2011) Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%. British Journal of Haematology, 152, 175181.
  • Nademanee, A., Schmidt, G.M., O’ Donnell, M.R., Snyder, D.S., Parker, P.A., Stein, A., Smith, E., Lipsett, J.A., Sniecinski, I. & Margolin, K. (1992) High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot study. Blood, 80, 11301134.
  • Nomura, Y., Karube, K., Suzuki, R., Ying, G., Takeshita, M., Hirose, S., Nakamura, S., Yoshino, T., Kikuchi, M. & Ohshima, K. (2008) High-grade mature B-cell lymphoma with Burkitt-like morphology: results of a clinico-pathological study of 72 Japanese patients. Cancer Science, 2, 246252.
  • Oriol, A., Ribera, J.M., Bergua, J., Giménez Mesa, E., Grande, C., Esteve, J., Brunet, S., Moreno, M.J., Escoda, L., Hernandez-Rivas, J.M. & Hoelzer, D. (2008) High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients. Cancer, 1, 117125.
  • Patte, C., Auperin, A., Gerrard, M., Michon, J., Pinkerton, R., Sposto, R., Weston, C., Raphael, M., Perkins, S.L., McCarthy, K. & Cairo, M.S. (2007) FAB/LMB96 International Study Committee. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood, 109, 27732780.
  • Peniket, A.J., Ruiz de Elvira, M.C., Taghipour, G., Cordonnier, C., Gluckman, E., de Witte, T., Santini, G., Blaise, D., Greinix, H., Ferrant, A., Cornelissen, J., Schmitz, N. & Goldstone, A.H. (2003) An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Bone Marrow Transplantation, 8, 667678.
  • Perkins, A.S. & Friedberg, J.W. (2008) Burkitt lymphoma in adults. Hematology/the Education Program of the American Society of Hematology, 2008, 341348.
  • Philip, T., Hartmann, O., Biron, P., Cahn, J.Y., Pein, F., Bordigoni, P., Souillet, G., Gartner, M., Lasset, C. & Chauvin, F. (1988) High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin’s lymphoma. Journal of Clinical Oncology, 7, 11181124.
  • Philip, T., Meckenstock, R., Deconnick, E., Carrie, C., Bailly, C., Colombat, P., Dauriac, C., Demaille, M.C., Salles, B. & Cahn, J.Y. (1992) Treatment of poor prognosis Burkitt’s lymphoma in adults with the Société Française d’Oncologie Pédiatrique LMB Protocol--a study of the Federation Nationale des Centres de Lutte Contre le Cancer (FNLCC). European Journal of Cancer, 12, 19541959.
  • Pui, C.H., Mahmoud, H.H., Wiley, J.M., Woods, G.M., Leverger, G., Camitta, B., Hastings, C., Blaney, S.M., Relling, M.V. & Reaman, G.H. (2001) Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. Journal of Clinical Oncology, 19, 697704.
  • Rizzieri, DA, Johnson, JL, Niedzwiecki, D, Lee, EJ, Vardiman, JW, Powell, BL, Barcos, M, Bloomfield, CD, Schiffer, CA, Peterson, BA, Canellos, GP & Larson, RA. (2004) Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of cancer and leukemia group B study 9251. Cancer, 7, 14381448.
  • Savage, K.J., Johnson, N.A., Ben-Neriah, S., Connors, J.M., Sehn, L.H., Farinha, P., Horsman, D.E. & Gascoyne, R.D. (2009) MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Blood, 17, 35333537.
  • Soussain, C., Patte, C., Ostronoff, M., Delmer, A., Rigal-Huguet, F., Cambier, N., Leprisé, P.Y., François, S., Cony-Makhoul, P. & Harousseau, J.L. (1995) Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood, 3, 664674.
  • Sparano, J.A., Lee, J.Y., Kaplan, L.D., Levine, A.M., Ramos, J.C., Ambinder, R.F., Wachsman, W., Aboulafia, D., Noy, A., Henry, D.H., Von Roenn, J., Dezube, B.J., Remick, S.C., Shah, M.H., Leichman, L., Ratner, L., Cesarman, E., Chadburn, A. & Mitsuyasu, R. (2010) Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood, 15, 30083016.
  • Sweetenham, J.W., Pearce, R., Taghipour, G., Blaise, D., Gisselbrecht, C. & Goldstone, A.H. (1996) Adult Burkitt’s and Burkitt-like non-Hodgkin’s lymphoma--outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European group for blood and marrow transplantation. Journal of Clinical Oncology, 9, 24652472.
  • Thomas, D.A., Faderl, S., O’Brien, S., Bueso-Ramos, C., Cortes, J., Garcia-Manero, G., Giles, F.J., Verstovsek, S., Wierda, W.G., Pierce, S.A., Shan, J., Brandt, M., Hagemeister, F.B., Keating, M.J., Cabanillas, F. & Kantarjian, H. (2006) Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer, 7, 15691580.
  • Troussard, X., Leblond, V., Kuentz, M., Milpied, N., Jouet, J.P., Cordonnier, C., Leporrier, M. & Vernant, J.P. (1990) Allogeneic bone marrow transplantation in adults with Burkitt’s lymphoma or acute lymphoblastic leukemia in first complete remission. Journal of Clinical Oncology, 5, 809812.
  • Wilson, W.H., Bryant, G., Bates, S., Fojo, A., Wittes, R.E., Steinberg, S.M., Kohler, D.R., Jaffe, E.S., Herdt, J. & Cheson, B.D. (1993) EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin’s lymphoma. Journal of Clinical Oncology, 8, 15731582.